enFoldX tops 8 neoantigen scans and an unseen-peptide benchmark
quaidmorris · x · 2026-07-22
enFoldX wins on one-residue neoantigen discrimination and unseen peptides
The thread adds two more evaluation settings for enFoldX:
- Neoantigen task: when cognate and non-cognate peptides differ by only one residue, enFoldX leads across 8 mutational-scan datasets with a median AUC of 0.71.
- IMMREP25 unseen-peptide challenge: for epitopes at least 4 substitutions away from anything published, enFoldX outperforms every sequence- and structure-based method.
The figures compare enFoldX with sequence and structure baselines and show it consistently on top or near the top.
More from Research
- Robotics paper says VLA and world models are not enough for grounded supervision — hbouammar · 2026-07-23
- AI could compress decades of biomedical research into days, says Derya Unutmaz — DeryaTR_ · 2026-07-23
- Applied Math Dominates AI, But Why Does Gradient Descent Actually Work? — fkasummer · 2026-07-23
- Cursor’s Composer 2.5 looks much worse at reasoning than its Kimi base model — gleech · 2026-07-23
- Lanyon says its neurosymbolic solver is 20–250x faster than frontier models — burny_tech · 2026-07-23
- Kimi K3 and Tinker power an autoresearch loop that ran 19 experiments — burny_tech · 2026-07-23